Annual EBITDA
-$13.33 M
-$3.74 M-38.97%
September 30, 2024
Summary
- As of February 7, 2025, APDN annual EBITDA is -$13.33 million, with the most recent change of -$3.74 million (-38.97%) on September 30, 2024.
- During the last 3 years, APDN annual EBITDA has fallen by -$1.65 million (-14.09%).
- APDN annual EBITDA is now -340.32% below its all-time high of $5.55 million, reached on September 30, 2009.
Performance
APDN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.19 M
+$18.20 K+0.57%
September 1, 2024
Summary
- As of February 7, 2025, APDN quarterly EBITDA is -$3.19 million, with the most recent change of +$18.20 thousand (+0.57%) on September 1, 2024.
- Over the past year, APDN quarterly EBITDA has increased by +$237.10 thousand (+6.91%).
- APDN quarterly EBITDA is now -130.85% below its all-time high of $10.36 million, reached on March 31, 2009.
Performance
APDN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$13.33 M
+$646.80 K+4.63%
September 1, 2024
Summary
- As of February 7, 2025, APDN TTM EBITDA is -$13.33 million, with the most recent change of +$646.80 thousand (+4.63%) on September 1, 2024.
- Over the past year, APDN TTM EBITDA has dropped by -$55.70 thousand (-0.42%).
- APDN TTM EBITDA is now -296.59% below its all-time high of $6.78 million, reached on December 31, 2009.
Performance
APDN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
APDN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.0% | +6.9% | -0.4% |
| 3 y3 years | -14.1% | -35.4% | -37.4% |
| 5 y5 years | -65.3% | -35.4% | -37.4% |
APDN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.0% | at low | -262.9% | +27.2% | -45.3% | +4.6% |
| 5 y | 5-year | -65.3% | at low | -262.9% | +27.2% | -76.9% | +4.6% |
| alltime | all time | -340.3% | +74.0% | -130.8% | +88.9% | -296.6% | +74.0% |
Applied DNA Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$13.33 M(+39.0%) | - | - |
| Sep 2024 | - | -$3.19 M(-0.6%) | -$13.33 M(-4.6%) |
| Jun 2024 | - | -$3.21 M(-6.4%) | -$13.98 M(+5.3%) |
| Mar 2024 | - | -$3.43 M(-1.7%) | -$13.27 M(+8.8%) |
| Dec 2023 | - | -$3.49 M(-9.1%) | -$12.20 M(+27.2%) |
| Sep 2023 | -$9.59 M(-24.4%) | -$3.84 M(+53.0%) | -$9.59 M(-0.9%) |
| Jun 2023 | - | -$2.51 M(+6.4%) | -$9.67 M(-0.3%) |
| Mar 2023 | - | -$2.36 M(+168.1%) | -$9.70 M(+5.7%) |
| Dec 2022 | - | -$880.10 K(-77.6%) | -$9.17 M(-27.6%) |
| Sep 2022 | -$12.68 M(+8.5%) | -$3.92 M(+54.8%) | -$12.68 M(+4.0%) |
| Jun 2022 | - | -$2.54 M(+38.3%) | -$12.19 M(-5.1%) |
| Mar 2022 | - | -$1.83 M(-58.2%) | -$12.84 M(-2.2%) |
| Dec 2021 | - | -$4.39 M(+27.8%) | -$13.13 M(+13.0%) |
| Sep 2021 | -$11.68 M(-4.6%) | -$3.43 M(+7.4%) | -$11.62 M(-4.4%) |
| Jun 2021 | - | -$3.19 M(+50.9%) | -$12.16 M(+0.6%) |
| Mar 2021 | - | -$2.12 M(-26.4%) | -$12.09 M(-4.0%) |
| Dec 2020 | - | -$2.88 M(-27.6%) | -$12.59 M(+2.8%) |
| Sep 2020 | -$12.25 M(+51.9%) | -$3.97 M(+27.0%) | -$12.25 M(+30.7%) |
| Jun 2020 | - | -$3.13 M(+19.5%) | -$9.37 M(+23.4%) |
| Mar 2020 | - | -$2.62 M(+3.1%) | -$7.60 M(+0.8%) |
| Dec 2019 | - | -$2.54 M(+132.1%) | -$7.53 M(-6.5%) |
| Sep 2019 | -$8.06 M(-27.3%) | -$1.09 M(-19.2%) | -$8.06 M(-21.8%) |
| Jun 2019 | - | -$1.35 M(-47.0%) | -$10.31 M(-11.9%) |
| Mar 2019 | - | -$2.55 M(-16.6%) | -$11.70 M(+5.0%) |
| Dec 2018 | - | -$3.06 M(-8.4%) | -$11.14 M(+0.4%) |
| Sep 2018 | -$11.10 M(-7.0%) | -$3.34 M(+21.9%) | -$11.10 M(+8.8%) |
| Jun 2018 | - | -$2.74 M(+37.5%) | -$10.20 M(+3.1%) |
| Mar 2018 | - | -$1.99 M(-33.9%) | -$9.89 M(-11.3%) |
| Dec 2017 | - | -$3.02 M(+23.5%) | -$11.16 M(-6.5%) |
| Sep 2017 | -$11.93 M(+3.8%) | -$2.44 M(+0.1%) | -$11.93 M(+1.5%) |
| Jun 2017 | - | -$2.44 M(-25.1%) | -$11.75 M(-6.5%) |
| Mar 2017 | - | -$3.26 M(-14.1%) | -$12.56 M(-0.1%) |
| Dec 2016 | - | -$3.79 M(+67.7%) | -$12.58 M(+9.5%) |
| Sep 2016 | -$11.49 M(+56.1%) | -$2.26 M(-30.5%) | -$11.49 M(+19.9%) |
| Jun 2016 | - | -$3.25 M(-0.7%) | -$9.58 M(+21.6%) |
| Mar 2016 | - | -$3.28 M(+21.2%) | -$7.88 M(+23.9%) |
| Dec 2015 | - | -$2.70 M(+669.0%) | -$6.36 M(-13.7%) |
| Sep 2015 | -$7.36 M(-37.8%) | -$351.40 K(-77.3%) | -$7.37 M(-24.4%) |
| Jun 2015 | - | -$1.55 M(-11.7%) | -$9.74 M(-7.8%) |
| Mar 2015 | - | -$1.76 M(-52.6%) | -$10.56 M(-10.7%) |
| Dec 2014 | - | -$3.71 M(+36.0%) | -$11.83 M(+0.0%) |
| Sep 2014 | -$11.83 M(+20.0%) | -$2.73 M(+14.8%) | -$11.83 M(+5.2%) |
| Jun 2014 | - | -$2.37 M(-21.4%) | -$11.24 M(-3.5%) |
| Mar 2014 | - | -$3.02 M(-18.5%) | -$11.65 M(+3.9%) |
| Dec 2013 | - | -$3.71 M(+73.5%) | -$11.21 M(+13.8%) |
| Sep 2013 | -$9.85 M(+59.1%) | -$2.14 M(-23.2%) | -$9.85 M(+4.0%) |
| Jun 2013 | - | -$2.78 M(+7.5%) | -$9.47 M(+18.2%) |
| Mar 2013 | - | -$2.59 M(+10.0%) | -$8.01 M(+17.3%) |
| Dec 2012 | - | -$2.35 M(+34.1%) | -$6.83 M(+10.3%) |
| Sep 2012 | -$6.19 M | -$1.75 M(+32.4%) | -$6.19 M(-23.8%) |
| Jun 2012 | - | -$1.32 M(-5.6%) | -$8.13 M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$1.40 M(-18.2%) | -$8.20 M(+3.7%) |
| Dec 2011 | - | -$1.71 M(-53.5%) | -$7.91 M(+9.4%) |
| Sep 2011 | -$7.69 M(+14.0%) | -$3.69 M(+163.4%) | -$7.23 M(+36.1%) |
| Jun 2011 | - | -$1.40 M(+25.9%) | -$5.31 M(-14.9%) |
| Mar 2011 | - | -$1.11 M(+7.7%) | -$6.24 M(+1.8%) |
| Dec 2010 | - | -$1.03 M(-41.6%) | -$6.13 M(-7.0%) |
| Sep 2010 | -$6.75 M(-221.6%) | -$1.77 M(-24.2%) | -$6.59 M(+11.4%) |
| Jun 2010 | - | -$2.33 M(+133.2%) | -$5.91 M(+29.3%) |
| Mar 2010 | - | -$999.20 K(-32.9%) | -$4.58 M(-167.5%) |
| Dec 2009 | - | -$1.49 M(+36.1%) | $6.78 M(+22.2%) |
| Sep 2009 | $5.55 M(-249.0%) | -$1.09 M(+10.5%) | $5.55 M(-6.6%) |
| Jun 2009 | - | -$990.80 K(-109.6%) | $5.94 M(-3.6%) |
| Mar 2009 | - | $10.36 M(-480.2%) | $6.16 M(-228.2%) |
| Dec 2008 | - | -$2.72 M(+287.8%) | -$4.81 M(+44.0%) |
| Sep 2008 | -$3.72 M(-60.0%) | -$702.30 K(-8.7%) | -$3.34 M(-60.4%) |
| Jun 2008 | - | -$769.40 K(+26.1%) | -$8.42 M(-6.4%) |
| Mar 2008 | - | -$610.10 K(-51.4%) | -$9.00 M(-3.4%) |
| Dec 2007 | - | -$1.25 M(-78.3%) | -$9.31 M(+0.2%) |
| Sep 2007 | -$9.30 M(-28.3%) | -$5.79 M(+330.7%) | -$9.30 M(-25.8%) |
| Jun 2007 | - | -$1.34 M(+45.2%) | -$12.54 M(+2.1%) |
| Mar 2007 | - | -$925.90 K(-25.3%) | -$12.28 M(-0.5%) |
| Dec 2006 | - | -$1.24 M(-86.3%) | -$12.34 M(-4.8%) |
| Sep 2006 | -$12.97 M(-74.7%) | -$9.03 M(+728.4%) | -$12.96 M(-60.4%) |
| Jun 2006 | - | -$1.09 M(+10.8%) | -$32.75 M(-5.0%) |
| Mar 2006 | - | -$983.50 K(-47.1%) | -$34.46 M(-21.5%) |
| Dec 2005 | - | -$1.86 M(-93.5%) | -$43.89 M(-14.5%) |
| Sep 2005 | -$51.35 M(+221.9%) | -$28.82 M(+927.8%) | -$51.30 M(+78.9%) |
| Jun 2005 | - | -$2.80 M(-73.1%) | -$28.67 M(+4.1%) |
| Mar 2005 | - | -$10.41 M(+12.2%) | -$27.54 M(+44.6%) |
| Dec 2004 | - | -$9.28 M(+50.0%) | -$19.04 M(+11.8%) |
| Sep 2004 | -$15.96 M(+360.0%) | -$6.19 M(+269.8%) | -$17.04 M(+11.8%) |
| Jun 2004 | - | -$1.67 M(-12.4%) | -$15.25 M(+9.7%) |
| Mar 2004 | - | -$1.91 M(-73.8%) | -$13.90 M(+11.9%) |
| Dec 2003 | - | -$7.27 M(+65.7%) | -$12.42 M(+134.5%) |
| Sep 2003 | -$3.47 M(>+9900.0%) | -$4.39 M(+1247.4%) | -$5.30 M(+484.6%) |
| Jun 2003 | - | -$325.90 K(-24.7%) | -$906.10 K(+56.2%) |
| Mar 2003 | - | -$433.00 K(+194.2%) | -$580.20 K(+294.2%) |
| Dec 2002 | - | -$147.20 K(>+9900.0%) | -$147.20 K(+1611.6%) |
| Dec 2001 | -$8600.00(+1128.6%) | -$200.00(-97.6%) | -$8600.00(0.0%) |
| Sep 2001 | - | -$8200.00(+8100.0%) | -$8600.00(+1333.3%) |
| Jun 2001 | - | -$100.00(0.0%) | -$600.00(-14.3%) |
| Mar 2001 | - | -$100.00(-50.0%) | -$700.00(-12.5%) |
| Dec 2000 | -$700.00(-79.4%) | -$200.00(0.0%) | -$800.00(-77.8%) |
| Sep 2000 | - | -$200.00(0.0%) | -$3600.00(+5.9%) |
| Jun 2000 | - | -$200.00(0.0%) | -$3400.00(0.0%) |
| Mar 2000 | - | -$200.00(-93.3%) | -$3400.00(0.0%) |
| Dec 1999 | -$3400.00(+112.5%) | -$3000.00(<-9900.0%) | -$3400.00(+750.0%) |
| Sep 1999 | - | $0.00(-100.0%) | -$400.00(0.0%) |
| Jun 1999 | - | -$200.00(0.0%) | -$400.00(+100.0%) |
| Mar 1999 | - | -$200.00 | -$200.00 |
| Dec 1998 | -$1600.00(+166.7%) | - | - |
| Dec 1997 | -$600.00 | - | - |
FAQ
- What is Applied DNA Sciences annual EBITDA?
- What is the all time high annual EBITDA for Applied DNA Sciences?
- What is Applied DNA Sciences annual EBITDA year-on-year change?
- What is Applied DNA Sciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Applied DNA Sciences?
- What is Applied DNA Sciences quarterly EBITDA year-on-year change?
- What is Applied DNA Sciences TTM EBITDA?
- What is the all time high TTM EBITDA for Applied DNA Sciences?
- What is Applied DNA Sciences TTM EBITDA year-on-year change?
What is Applied DNA Sciences annual EBITDA?
The current annual EBITDA of APDN is -$13.33 M
What is the all time high annual EBITDA for Applied DNA Sciences?
Applied DNA Sciences all-time high annual EBITDA is $5.55 M
What is Applied DNA Sciences annual EBITDA year-on-year change?
Over the past year, APDN annual EBITDA has changed by -$3.74 M (-38.97%)
What is Applied DNA Sciences quarterly EBITDA?
The current quarterly EBITDA of APDN is -$3.19 M
What is the all time high quarterly EBITDA for Applied DNA Sciences?
Applied DNA Sciences all-time high quarterly EBITDA is $10.36 M
What is Applied DNA Sciences quarterly EBITDA year-on-year change?
Over the past year, APDN quarterly EBITDA has changed by +$237.10 K (+6.91%)
What is Applied DNA Sciences TTM EBITDA?
The current TTM EBITDA of APDN is -$13.33 M
What is the all time high TTM EBITDA for Applied DNA Sciences?
Applied DNA Sciences all-time high TTM EBITDA is $6.78 M
What is Applied DNA Sciences TTM EBITDA year-on-year change?
Over the past year, APDN TTM EBITDA has changed by -$55.70 K (-0.42%)